Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

Completed · Phase 4 · Has a placebo group

Conditions studied: Alcohol Related Disorders

In brief

The study objective was to determine if liver injury develops in alcoholic patients during or following 5 days of therapeutic acetaminophen dosing. Volunteers were recruited from two community detoxification centers to take either acetaminophen (4g/day) or placebo for 5 consecutive days. All subjects were monitored an additional two days following the dosing period. The primary measures were aminotransferase measures taken at baseline and Days 2, 4, 6 and 7. We hypothesized that there would be no difference in aminotransferase means between the groups at any study period.

Key facts

Study ID
NCT00427206
Run by
Denver Health and Hospital Authority
People needed
181
Starts
2004-11-01
Expected to finish
2005-12-01
Last updated by the study team
2009-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.